Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
GRFS
GRFS
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
GRFS News
Grifols Obtains FDA Approval to Introduce Fesilty in the US by Mid-2026
Dec 19 2025
NASDAQ.COM
Daily Upgrade Report for Validea's Joseph Piotroski Strategy - November 26, 2025
Nov 26 2025
NASDAQ.COM
Daily Upgrade Report for Validea's Joseph Piotroski Strategy - October 10, 2025
Oct 10 2025
NASDAQ.COM
Everything You Should Know About Grifols (GRFS) Upgrade to Buy Rating
Aug 28 2025
NASDAQ.COM
Grifols S.A. declares $0.1404 dividend
Aug 01 2025
SeekingAlpha
Verona Pharma, Rhythm Pharmaceuticals, AES And Other Big Stocks Moving Higher On Wednesday
Jul 09 2025
Benzinga
Analysts Anticipate KOMP To Hit $60
Jun 24 2025
NASDAQ.COM
JP Morgan Maintains Neutral on Grifols, Raises Price Target to $10.3
Jun 17 2025
Benzinga
Why Sportsman's Warehouse Shares Are Trading Higher By Around 39%; Here Are 20 Stocks Moving Premarket
Apr 02 2025
Benzinga
Biggest stock movers Wednesday: NCNO, TTEC, GRFS and more
Apr 02 2025
SeekingAlpha
Brookfield resumes Grifols takeover talks for €7 billion - report
Apr 02 2025
SeekingAlpha
Validea Joseph Piotroski Strategy Daily Upgrade Report - 4/22/2025
Apr 01 2025
NASDAQ.COM
KOMP's Underlying Holdings Could Mean 26% Gain Potential
Mar 26 2025
NASDAQ.COM
Grifols price target raised to EUR 11 from EUR 10 at Deutsche Bank
Mar 10 2025
Business Insider
Grifols sees reaching EUR 10B in revenue by 2029
Feb 27 2025
Business Insider
Grifols sees 2025 revenue EUR 7.7B, EBITDA above EUR 2B
Feb 27 2025
Business Insider
Show More News
